Eliem Therapeutics at the 5th Annual Evercore ISI HealthCONx Virtual Conference
30 November 2022 - 11:00PM
Eliem Therapeutics, Inc. (Nasdaq: ELYM), a clinical-stage
biotechnology company focused on developing novel therapies for
neuronal excitability disorders to address unmet needs in
psychiatry, epilepsy, chronic pain, and other disorders of the
peripheral and central nervous systems, today announced that Bob
Azelby, Eliem’s president and chief executive officer, will present
at the 5th Annual Evercore ISI HealthCONx Virtual Conference being
held virtually on Thursday, December 1, 2022 at 11:40 AM ET.
A live webcast will be available on the Investors section of the
Eliem Therapeutics website at https://www.eliemtx.com. An archived
replay will remain available on Eliem’s website for at least 30
days after the conference.
About Eliem Therapeutics, Inc.
Eliem Therapeutics, Inc. is a clinical-stage biotechnology
company focused on developing novel therapies for neuronal
excitability disorders to address unmet needs in psychiatry,
epilepsy, chronic pain, and other disorders of the peripheral and
central nervous systems. These disorders often occur when neurons
are overly excited or inhibited, leading to an imbalance, and our
focus is on restoring homeostasis. We are developing a pipeline of
clinically differentiated product candidates focused on validated
mechanisms of action with broad therapeutic potential to deliver
improved therapeutics for patients with these disorders. Eliem
channels its experience, energy, and passion for improving
patients’ quality of life to fuel our efforts to develop
life-changing novel therapies. At its core, the Eliem team is
motivated by the promise of helping patients live happier, more
fulfilling lives.
https://eliemtx.com/
InvestorsChris Brinzey ICR
Westwickechris.brinzey@westwicke.com339-970-2843
MediaMarites CoulterVerge
ScientificMcoulter@vergescientific.com415.819.2214
Eliem Therapeutics (NASDAQ:ELYM)
Historical Stock Chart
From Mar 2024 to Apr 2024
Eliem Therapeutics (NASDAQ:ELYM)
Historical Stock Chart
From Apr 2023 to Apr 2024